Medtronic plc [NYSE: MDT] surged by $2.9 during the normal trading session on Friday and reaching a high of $112.69 during the day while it closed the day at $112.50. The company report on November 14, 2020 that Medtronic Ranked as a Leading Sustainability Company.
Strong ESG Practices Results in Inclusion on North American Dow Jones Sustainability Index (DJSI) for 13th Consecutive Year.
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced that it has been recognized as one of the world’s leading companies for sustainability with its inclusion in the Dow Jones Sustainability North America Index (DJSI North America). The DJSI North America includes a select group of companies based on their performance across a variety of sustainability criteria, including economic performance, environmental stewardship, social responsibility, and corporate governance. This is the 13th consecutive year Medtronic has placed on the prestigious list, considered to be a leading benchmark for corporate sustainability.
Medtronic plc stock has also gained 8.63% of its value over the past 7 days. However, MDT stock has inclined by 10.45% in the 3 months of the year. Over the past six months meanwhile, it has gained 13.75% and lost -0.84% year-on date.
The market cap for MDT stock reached $147.33 billion, with 1.34 billion shares outstanding and 1.34 billion shares in the current float. Compared to the average trading volume of 4.72M shares, MDT reached a trading volume of 3622110 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Medtronic plc [MDT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MDT shares is $118.79 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MDT stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Stifel have made an estimate for Medtronic plc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 08, 2020. The new note on the price target was released on October 08, 2020, representing the official price target for Medtronic plc stock. Previously, the target price had yet another raise to $115, while Wolfe Research analysts kept a Peer Perform rating on MDT stock.
The Average True Range (ATR) for Medtronic plc is set at 3.37, with the Price to Sales ratio for MDT stock in the period of the last 12 months amounting to 5.28. The Price to Book ratio for the last quarter was 3.00, with the Price to Cash per share for the same quarter was set at 9.94. Price to Free Cash Flow for MDT in the course of the last twelve months was 81.49 with Quick ratio for the last quarter at 1.50.
MDT stock trade performance evaluation
Medtronic plc [MDT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 8.63. With this latest performance, MDT shares gained by 4.63% in over the last four-week period, additionally plugging by 13.75% over the last 6 months – not to mention a rise of 3.01% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MDT stock in for the last two-week period is set at 59.16, with the RSI for the last a single of trading hit 62.74, and the three-weeks RSI is set at 58.65 for Medtronic plc [MDT]. The present Moving Average for the last 50 days of trading for this stock 106.18, while it was recorded at 112.02 for the last single week of trading, and 100.04 for the last 200 days.
Medtronic plc [MDT]: An insightful look at the core fundamentals
Medtronic plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.50 and a Current Ratio set at 1.90.
Earnings per share (EPS) analysis for Medtronic plc [MDT] stock
With the latest financial reports released by the company, Medtronic plc posted 1.31/share EPS, while the average EPS was predicted by analysts to be reported at 1.28/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 2.30%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MDT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Medtronic plc go to 9.41%.
Medtronic plc [MDT]: Insider Ownership positions
There are presently around $122,624 million, or 84.00% of MDT stock, in the hands of institutional investors. The top three institutional holders of MDT stocks are: VANGUARD GROUP INC with ownership of 113,112,650, which is approximately -3.926% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 112,167,184 shares of the stock with an approximate value of $12.62 billion in MDT stocks shares; and STATE STREET CORP, currently with $6.52 billion in MDT stock with ownership of nearly -1.487% of the company’s market capitalization.
914 institutional holders increased their position in Medtronic plc [NYSE:MDT] by around 40,674,992 shares. Additionally, 770 investors decreased positions by around 65,122,643 shares, while 209 investors held positions by with 984,189,921 shares. The mentioned changes placed institutional holdings at 1,089,987,556 shares, according to the latest SEC report filing. MDT stock had 138 new institutional investments in for a total of 8,228,424 shares, while 98 institutional investors sold positions of 5,039,867 shares during the same period.